Curcumin as a complementary treatment in oncological therapy: a systematic review.

Purpose: Curcumin, the active ingredient in turmeric, is employed by numerous cancer patients to support conventional cancer therapy. This systematic review aims to summarize the existing clinical evidence and to provide an overview of the potential benefits and risks associated with curcumin supple...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 81; no. 1; pp. 1 - 34
Autores principales: Gutsche, Lisa C., Dörfler, Jennifer, Hübner, Jutta
Formato: research systematic review tables/charts Journal Article
Publicado: Springer Nature Jan2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=182077093&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 182077093
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Jan2025
      vid: 81
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        182077093
        180325309
        182077093
        182077093
        10.1007/s00228-024-03764-9
        182077093
      ppf: 1
      ppct: 33
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Curcumin as a complementary treatment in oncological therapy: a systematic review.
      aug:
        au:
          Gutsche, Lisa C.
          Dörfler, Jennifer
          Hübner, Jutta
        affil: https://ror.org/03kxagd85 Klinik für Innere Medizin II, Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, 07747, Am Klinikum 1, Jena, Germany
      sug:
        subj:
          Neoplasms Drug Therapy
          Curcumin Therapeutic Use
          Curcumin Adverse Effects
          Dietary Supplements
          Alternative Therapies
          Drug Efficacy
          Human
          Male
          Female
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Systematic Review
          Embase
          Cochrane Library
          Psycinfo
          CINAHL Database
          Medline
          Curcumin Administration and Dosage
          Body Weight Changes
          Body Composition
          Survival Rate
          Disease Progression
          Stomatitis
          Vomiting Chemically Induced
          Head and Neck Neoplasms Drug Therapy
          Breast Neoplasms Drug Therapy
          Prostatic Neoplasms Drug Therapy
          Colorectal Neoplasms Drug Therapy
          Cancer Patients
          Checklists
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Purpose: Curcumin, the active ingredient in turmeric, is employed by numerous cancer patients to support conventional cancer therapy. This systematic review aims to summarize the existing clinical evidence and to provide an overview of the potential benefits and risks associated with curcumin supplementation. Methods: In January 2024, we conducted a systematic search of five electronic databases (Embase, Cochrane, PsycInfo, CINAHL, and Medline) using a complex search strategy. We included randomized controlled trials on the use, effectiveness, and potential harm of additional curcumin therapy in adult patients under cancer treatment. The risk of bias was assessed using Cochrane revised Risk of Bias Tool 2.0. Results: This systematic review included 34 randomized controlled trials involving 2580 patients out of 11143 search results. Included patients were primarily diagnosed with head and neck cancer, followed by breast, prostate, and colorectal cancer. Therapy concepts encompassed topical or systemic curcumin administration. The studies reported heterogeneous results concerning oral and skin symptoms, pain, weight alteration and changes in body composition, survival, and disease progression. Significant findings were reported for oral mucositis and weight loss. Considering risk of bias, all studies had moderate to high risk of bias. Regarding side effects, one study reported significantly more vomiting in the curcumin group. Conclusion: Although the results suggest promise in reducing mucositis and weight loss, a clear statement regarding the effectiveness of curcumin therapy on cancer patients cannot be made due to heterogeneous results and methodological limitations of the involved studies. Further investigations of higher quality are necessary to derive a definite recommendation for action.
      pubtype: Academic Journal
      doctype:
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N